Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer
Abstract Copy number gene amplification and associated overexpression of driver oncogenes are genetic events that contribute to cancer progression and drug resistance. MDS1 and EVI1 Complex locus (MECOM) gene is copy number amplified and overexpressed in aggressive epithelial ovarian cancers. The bi...
Saved in:
| Main Authors: | Ibha Singh, Amarnath Karna, Anita Prajapati, Ujjawal Solanki, Archana Mukherjee, Sheetal Uppal, Pawan Malhotra, Manoj Kumar, Pallavi Agarwal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02618-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic pan-cancer analysis of the prognostic value of MECOM in human cancer
by: Yingqiang Lu, et al.
Published: (2024-11-01) -
A novel Mecom gene mutation associated with amegakaryocytic thrombocytopenia in a premature infant
by: Burak Deliloğlu, et al.
Published: (2022-08-01) -
A novel MECOM gene variant causes severe thrombocytopenia in a neonate: a case report and review of the literature
by: Jiaxin Li, et al.
Published: (2025-04-01) -
Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature
by: Soumya Mikkilineni, et al.
Published: (2025-04-01) -
RUNX1::MECOM rearrangement in myeloid neoplasm post cytotoxic therapy following sarcoma treatment: a case presentation and review of the literature
by: Miriam Sandnes, et al.
Published: (2025-12-01)